ABIC 2015 This year’s Agricultural Bioscience International Conference found a welcoming home in Melbourne, Australia. Multinationals such as Bayer CropScience, Monsanto, Syngenta, and Pepsi, mingled with research groups and businesses from Australasia including CSIRO, AgResearch, and a full complement of universities. The three-day conference explored the thorny issues around innovation in agritech, its global applications, and public perception….

Read More

Part four of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. New South Wales is home to approximately 200 life science companies and exports over AUD2 billion (USD1.4 billion) in pharmaceuticals and medical devices annually….

Read More

Part three of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney.   Queensland, and its capital city Brisbane, are well known both in Australia and globally for their strengths in pre-farm gate technology, tropical health,…

Read More

Part two of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. Melbourne is globally recognised for its strengths in clinical trials, stem cell research and cancer therapies. Greater Melbourne includes 27 biotechnology research institutes, nine…

Read More

Part one of our four-part spotlight on Australia. In this series of short articles, we profile Australia and three of its main cities for life sciences innovation: Melbourne, Brisbane, and Sydney. The latest Scientific American Worldview Scorecard 2015 ranked Australia number four in biotechnology in the world. Significantly, Scientific American commented that if ranking was…

Read More

Singapore, New Zealand, and Australia have been named as the world’s first, fourth, and fifteenth most attractive foreign investment nations by a US economic think tank. The Milken Institute recently released its annual Global Opportunity Index, which ranks countries within a framework of costs and conditions of doing business. It is particularly policy focused but…

Read More

Food innovations developed in New Zealand have a high degree of diversity and sustainability that can be directly attributed to the unique and deep natural resources offered by the country’s geographical remoteness and mild climate. High quality meat, dairy, fruit, wine, seafood, and a wide range of natural product ingredients have made New Zealand a…

Read More

With dairy a major component of New Zealand’s economy, it should come as little surprise that our researchers are internationally recognised for their work to add value in this space. One of the key universities in this industry is Massey University. In keeping with its high international regard, Massey’s Professor Hajinder Singh has been awarded the 2015 International Dairy…

Read More

In an interview with BiotechDispatch following his address to the Parliamentary Friends of Medicines event in Canberra, Ken Frazier, President and CEO of US-based Merck, one of the world’s largest biopharmaceutical companies and biggest investors in R&D, predicted human biology would be the next great driver of health innovation. According to Frazier, there is an…

Read More

The Asia-Pacific region has once again shown its strength in the 2015 Scientific American Worldview Scorecard rankings, holding three of the Top Five spots. Released at this year’s BIO International Convention, the report evaluates countries on key factors that power biotechnology success. Life science innovation potential is measured using seven categories: productivity, IP protection, intensity,…

Read More